相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Impact of ERK5 on the Hallmarks of Cancer
Barbara Stecca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MEK5 promotes lung adenocarcinoma
Adrian Sanchez-Fdez et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains
Jinhua Wang et al.
ACS CHEMICAL BIOLOGY (2018)
Scientific Advances in Thoracic Oncology 2016
Ross A. Soo et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target
Andre E. S. Simoes et al.
DRUG DISCOVERY TODAY (2016)
Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma
Paul R. Gavine et al.
BMC CANCER (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma
Elisabetta Rovida et al.
GUT (2015)
Genetic and Pharmacologic Evidence That mTOR Targeting Outweighs mTORC1 Inhibition as an Antimyeloma Strategy
Xi Chen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer
J. C. Montero et al.
ONCOGENE (2014)
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma
Ganesh Umapathy et al.
SCIENCE SIGNALING (2014)
Therapeutic potential of ERK5 targeting in triple negative breast cancer
Maria Jesus Ortiz-Ruiz et al.
ONCOTARGET (2014)
A functional polymorphism in the promoter of ERK5 gene interacts with tobacco smoking to increase the risk of lung cancer in Chinese populations
Fuman Qiu et al.
MUTAGENESIS (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
ERK5 and its role in tumour development
Pamela A. Lochhead et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Targeting the BMK1 MAP Kinase Pathway in Cancer Therapy
Qingkai Yang et al.
CLINICAL CANCER RESEARCH (2011)
Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein
Qingkai Yang et al.
CANCER CELL (2010)
Genome-wide association study identifies five loci associated with lung function
Emmanouela Repapi et al.
NATURE GENETICS (2010)
ERK5 is a Target for Gene Amplification at 17p11 and Promotes Cell Growth in Hepatocellular Carcinoma by Regulating Mitotic Entry
Keika Zen et al.
GENES CHROMOSOMES & CANCER (2009)
Identification of pharmacological inhibitors of the MEK5/ERK5 pathway
Revati J. Tatake et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation
Hiroko Morimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Erk5 nuclear location is independent on dual phosphorylation, and favours resistance to TRAIL-induced apoptosis
Joana Borges et al.
CELLULAR SIGNALLING (2007)
Regulation of cellular functions by the ERK5 signalling pathway
X Wang et al.
CELLULAR SIGNALLING (2006)
MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats
CY Zhong et al.
CARCINOGENESIS (2005)
Epidermal growth factor independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression
JR Jiang et al.
CANCER RESEARCH (2005)
Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis
M Hayashi et al.
CANCER RESEARCH (2005)
Cyclin C/Cdk3 promotes Rb-dependent G0 exit
SJ Ren et al.
CELL (2004)
Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2
A Esparis-Ogando et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
